| ||
| ARIAD Announces Broader Profile of Its Investigational Lung Cancer Drug ... Business Wire (press release) Coupled with desirable pharmacologic properties, these characteristics confer a best-in-class potential in non-small cell lung cancer (NSCLC). ARIAD expects to file an IND for AP26113 in 2Q11 and to begin a Phase 1/2 clinical trial based on patients' ... See all stories on this topic » | ||
| Cancer deaths drop but least-educated at high risk MarketWatch The effect of this disparity is on full display with lung cancer, where the death rate for men in 2007 was five times higher among the least educated compared with the most educated, said Elizabeth Ward, an Atlanta-based author of the report and ... See all stories on this topic » | ||
| Analyst: Lilly drug poised for continued growth Forbes Alimta is already approved to treat patients with a subset of non-small cell lung cancer as both a first-line treatment or a second option when the disease progresses. It also can be used as a maintenance treatment, but Lilly is seeking to update the ... See all stories on this topic » | ||
| Researchers Identify New Target in Cancer Fight Voice of America "So we were able to inhibit half of all the tumor growth in pancreatic cancer, breast cancer, melanoma, lung cancer. And there's every reason to believe that any other solid tumor cancer would be also responsive." Varner says suppressing PI-3 kinase ... See all stories on this topic » | ||
| Sachem Alum's Stem Cell Paper Wins Patch.com He is currently at Harvard completing his PhD. Last year he published the paper in Cell Magazine. The paper's subject matter is "primary tumor genotype is an important determinant in identification of lung cancer propagating cells. ... See all stories on this topic » | ||
| Size matters -- in virulent fungal spores -- and suggests ways to stop a killer EurekAlert (press release) "Clinically, these mucor infections are reasonably common in diabetic patients, transplant patients, and lung-cancer chemotherapy patients," he said. "Having a high blood-glucose level is immunosuppressive, and predisposes diabetic patients to ... See all stories on this topic » | ||
| A stem cell target for expanding waistlines? EurekAlert (press release) "Other peptides isolated in our study, based on their homing to lung, muscle, and bone marrow stromal cells, set the foundation for subsequent identification of protein interactions marking stromal progenitors of these organs." See all stories on this topic » |
| ||
| Analyst: Lilly drug poised for continued growth | The Associated ... By The Associated Press Alimta is already approved to treat patients with a subset of non-small cell lung cancer as both a first-line treatment or a second option when the disease progresses. It also can be used as a maintenance treatment, but Lilly is seeking ... Examiner News RSS |
| ||
| Scientists Identify Key Component In Lethal Lung Cancer Complication The protein, called the calcium-sensing receptor, sits on the surface of lung cancer cells that make up tumors known as squamous-cell carcinomas, ... researchnews.osu.edu/archive/hypercalc.htm | ||
| Get Treatment Of Small Cell Lung Cancer In India At Best Hospitals ... Two main form lung cancer you'll find are: Small-cell united states andNon-small -cell carcinoma of the lung. Small-cell united states accounts approximately ... americancancersocietydonations.tk/get-treatment-of-small-cell-... |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment